Home › Cancro ovarico › California › Mountain View
Studi clinici su Cancro ovarico a Mountain View, CA
19 studi su Cancro ovarico cercano partecipanti presso sedi a Mountain View e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
In reclutamentoFase 2/3
- Stanford Cancer Institute Palo Alto, Palo Alto · a 5 mi di distanza
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · a 5 mi di distanza
- VA Palo Alto Health Care System, Palo Alto · a 5 mi di distanza
A Study of PHST001 in Advanced Solid Tumors
In reclutamentoFase 1
- Stanford University School of Medicine, Palo Alto · a 5 mi di distanza
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- Stanford University, Palo Alto · a 5 mi di distanza
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
In reclutamentoFase 3
- Stanford Women's Cancer Center, Palo Alto · a 5 mi di distanza
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
In reclutamentoFase 1
- Stanford University Medical Center, Stanford · a 5 mi di distanza
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- Stanford Cancer Institute, Stanford · a 5 mi di distanza
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
In reclutamentoFase 1
- Stanford University, Palo Alto · a 5 mi di distanza
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
In reclutamentoFase 1
- Stanford, Palo Alto · a 5 mi di distanza
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
In reclutamentoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · a 5 mi di distanza
- e altri 1
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
In reclutamentoFase 2
- 150, Palo Alto · a 5 mi di distanza
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
In reclutamentoFase 3
- Palo Alto Medical Foundation, Palo Alto · a 5 mi di distanza
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Stanford University, Stanford · a 5 mi di distanza
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
In reclutamentoFase 1/2
- Stanford Women's Cancer Center, Palo Alto · a 5 mi di distanza
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
In reclutamentoStudio osservazionale
- Stanford University School of Medicine, Stanford · a 5 mi di distanza
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
In reclutamentoFase 1/2
- Stanford Cancer Institute, Stanford · a 5 mi di distanza
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
In reclutamentoFase 3
- Stanford Ambulatory Surgery Center Lane Operating Room, Palo Alto · a 5 mi di distanza
- Stanford Women's Cancer Center, Palo Alto · a 5 mi di distanza
- Stanford Hospital, Palo Alto · a 5 mi di distanza
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
In reclutamentoFase 2
- Stanford Cancer Center, Palo Alto · a 5 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Stanford · a 5 mi di distanza
Studi su Cancro ovarico in altre città
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Altri studi a Mountain View
- Cancro (tutti i tipi)40 studi
- Cancro al seno26 studi
- Cancro metastatico25 studi
- Cancro del polmone non a piccole cellule21 studi
- Leucemia mieloide acuta19 studi
- Disturbo dello spettro autistico17 studi
- Cancro ai polmoni17 studi
- Cancro alla prostata15 studi
- Insufficienza cardiaca15 studi
- Autismo13 studi
- Leucemia linfoblastica acuta13 studi
- Cancro colorettale13 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.